Novartis Capital has raised $5 billion in a three-part senior notes sale, The Wall Street Journal reports. The proceeds will be used to fund the takeover of a 52% stake in eye-care products maker, Alcon, from Nestle.

The size of the deal was increased from an initially proposed $4 billion. The joint bookrunning managers for the issue were Goldman Sachs, JP Morgan, Bank of America Merrill Lynch, Barclays Capital, Citigroup and Morgan Stanley.

Click here for the story from The Wall Street Journal.

Click here for additional coverage from Reuters.